Published in Med Care on September 01, 2003
Dynamic microsimulation models for health outcomes: a review. Med Decis Making (2010) 1.18
The role of economic evaluation in the decision-making process of family physicians: design and methods of a qualitative embedded multiple-case study. BMC Fam Pract (2009) 0.75
Common variants at 19p13 are associated with susceptibility to ovarian cancer. Nat Genet (2010) 4.51
Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer. Nat Genet (2013) 4.35
A genome-wide association study identifies susceptibility loci for ovarian cancer at 2q31 and 8q24. Nat Genet (2010) 3.86
GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer. Nat Genet (2013) 3.42
Cost analysis of ongoing care of patients with end-stage renal disease: the impact of dialysis modality and dialysis access. Am J Kidney Dis (2002) 3.06
An economic evaluation of activated protein C treatment for severe sepsis. N Engl J Med (2002) 2.69
Health care priority setting: principles, practice and challenges. Cost Eff Resour Alloc (2004) 2.59
Cost of acute renal failure requiring dialysis in the intensive care unit: clinical and resource implications of renal recovery. Crit Care Med (2003) 2.13
The role of KRAS rs61764370 in invasive epithelial ovarian cancer: implications for clinical testing. Clin Cancer Res (2011) 2.09
Type I and II endometrial cancers: have they different risk factors? J Clin Oncol (2013) 2.01
Setting priorities and allocating resources in health regions: lessons from a project evaluating program budgeting and marginal analysis (PBMA). Health Policy (2003) 1.91
Setting priorities in Canadian regional health authorities: a survey of key decision makers. Health Policy (2002) 1.83
Epigenetic analysis leads to identification of HNF1B as a subtype-specific susceptibility gene for ovarian cancer. Nat Commun (2013) 1.73
Special care facility compared with traditional environments for dementia care: a longitudinal study of quality of life. J Am Geriatr Soc (2004) 1.71
Paternal age is positively linked to telomere length of children. Aging Cell (2005) 1.69
Economics and obesity: costing the problem or evaluating solutions? Obes Res (2004) 1.63
Programme budgeting and marginal analysis: bridging the divide between doctors and managers. BMJ (2005) 1.52
Ethics and economics: does programme budgeting and marginal analysis contribute to fair priority setting? J Health Serv Res Policy (2006) 1.52
Rapid evaluation after high-risk TIA is associated with lower stroke risk. Can J Neurol Sci (2009) 1.45
A feasibility study of transcutaneous posterior tibial nerve stimulation for bladder and bowel dysfunction in elderly adults in residential care. J Am Med Dir Assoc (2012) 1.45
Searchers vs surveyors in estimating the monetary value of a QALY: resolving a nasty dilemma for NICE. Health Econ Policy Law (2011) 1.42
Identification and molecular characterization of a new ovarian cancer susceptibility locus at 17q21.31. Nat Commun (2013) 1.36
Using economics to set pragmatic and ethical priorities. BMJ (2006) 1.33
Deriving distributional weights for QALYs through discrete choice experiments. J Health Econ (2011) 1.24
Priority setting in a Canadian surgical department: a case study using program budgeting and marginal analysis. Can J Surg (2003) 1.24
Valuing the benefits and costs of health care programmes: where's the 'extra' in extra-welfarism? Soc Sci Med (2003) 1.24
Managing to manage healthcare resources in the English NHS? What can health economics teach? What can health economics learn? Health Policy (2007) 1.22
Functional polymorphisms in the TERT promoter are associated with risk of serous epithelial ovarian and breast cancers. PLoS One (2011) 1.20
Economic evaluation of weight loss interventions in overweight and obese women. Obesity (Silver Spring) (2006) 1.20
Case-control study of the metabolic syndrome and metabolic risk factors for endometrial cancer. Cancer Epidemiol Biomarkers Prev (2011) 1.20
Using PBMA in health care priority setting: description, challenges and experience. Appl Health Econ Health Policy (2003) 1.19
Detailed cost analysis of care for survivors of severe sepsis. Crit Care Med (2004) 1.19
The health-care system: an assessment and reform agenda. Lancet (2009) 1.19
Priority setting in health authorities: a novel approach to a historical activity. Soc Sci Med (2003) 1.17
A review of p53 expression and mutation in human benign, low malignant potential, and invasive epithelial ovarian tumors. Cancer (2003) 1.15
The impact of using different costing methods on the results of an economic evaluation of cardiac care: microcosting vs gross-costing approaches. Health Econ (2009) 1.14
Hepatocellular carcinoma incidence trends in Canada: analysis by birth cohort and period of diagnosis. Liver Int (2008) 1.13
Clinical and economic evaluation of rapid influenza a virus testing in nursing homes in calgary, Canada. Clin Infect Dis (2002) 1.10
Best worst discrete choice experiments in health: methods and an application. Soc Sci Med (2012) 1.10
Valuing health care using willingness to pay: a comparison of the payment card and dichotomous choice methods. J Health Econ (2004) 1.09
Biofilm formation by group a streptococci: is there a relationship with treatment failure? J Clin Microbiol (2003) 1.08
An economic evaluation of operative compared with nonoperative management of displaced intra-articular calcaneal fractures. J Bone Joint Surg Am (2005) 1.07
What needs to be done in contingent valuation: have Smith and Sach missed the boat? Health Econ Policy Law (2010) 1.07
Case-control study of lifetime total physical activity and endometrial cancer risk. Cancer Causes Control (2010) 1.05
Systematic review of stroke thrombolysis service configuration. Expert Rev Neurother (2009) 1.05
The impact of race and comorbidity on survival in endometrial cancer. Cancer Epidemiol Biomarkers Prev (2012) 1.01
Incidence of leukemia in Asian migrants to the United States and their descendants. Cancer Causes Control (2002) 1.00
Overcoming barriers to priority setting using interdisciplinary methods. Health Policy (2009) 1.00
Costs of rheumatoid arthritis: new estimates from the human capital method and comparison to the willingness-to-pay method. Med Decis Making (2007) 1.00
Willingness to pay for public health care: a comparison of two approaches. Health Policy (2004) 0.99
Genome-wide association study of subtype-specific epithelial ovarian cancer risk alleles using pooled DNA. Hum Genet (2013) 0.99
Valuing the benefits of weight loss programs: an application of the discrete choice experiment. Obes Res (2004) 0.98
Dialysis adequacy and health related quality of life in hemodialysis patients. ASAIO J (2002) 0.97
Choosing the method to match the perspective: economic assessment and its implications for health-services efficiency. Lancet (2002) 0.95
Illustrating the impact of including future costs in economic evaluations: an application to end-stage renal disease care. Health Econ (2003) 0.95
Willingness to pay for a QALY: past, present and future. Expert Rev Pharmacoecon Outcomes Res (2008) 0.95
Social enterprise: new pathways to health and well-being? J Public Health Policy (2012) 0.95
Should we use willingness to pay to elicit community preferences for health care? New evidence from using a 'marginal' approach. J Health Econ (2002) 0.93
Genome-wide association study of endometrial cancer in E2C2. Hum Genet (2013) 0.93
Using participatory action research to build a priority setting process in a Canadian Regional Health Authority. Soc Sci Med (2006) 0.92
Case-control study of markers of insulin resistance and endometrial cancer risk. Endocr Relat Cancer (2012) 0.92
Estimating a WTP-based value of a QALY: the 'chained' approach. Soc Sci Med (2013) 0.91
Morphologic and Molecular Characteristics of Mixed Epithelial Ovarian Cancers. Am J Surg Pathol (2015) 0.91
Colorectal cancer screening among first-degree relatives of colorectal cancer patients: benefits and barriers. Ann Surg Oncol (2009) 0.91
Evaluation of the impact of program budgeting and marginal analysis in Vancouver Island Health Authority. J Health Serv Res Policy (2009) 0.90
BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian Cancers. J Natl Cancer Inst (2015) 0.90
Paying for treatments? Influences on negotiating clinical need and decision-making for dental implant treatment. BMC Health Serv Res (2009) 0.90
Dietary intake and risk of postmenopausal breast cancer (United States). Cancer Causes Control (2003) 0.90
Risk of ovarian cancer and the NF-κB pathway: genetic association with IL1A and TNFSF10. Cancer Res (2013) 0.89
A cross-sectional study of intima-media thickness, ethnicity, metabolic syndrome, and cardiovascular risk in 2268 study participants. Mayo Clin Proc (2009) 0.89
Modelling the monetary value of a QALY: a new approach based on UK data. Health Econ (2009) 0.89
Commissioning NHS dentistry in England: issues for decision-makers managing the new contract with finite resources. Health Policy (2008) 0.88
The new myth: the social value of the QALY. Pharmacoeconomics (2008) 0.88
Catastrophic healthcare payments and impoverishment in the occupied Palestinian territory. Appl Health Econ Health Policy (2010) 0.87
Decision maker views on priority setting in the Vancouver Island Health Authority. Cost Eff Resour Alloc (2008) 0.87
Case study on priority setting in rural Southern Alberta: keeping the house from blowing in. Can J Rural Med (2004) 0.86
Association between sex hormones, glucose homeostasis, adipokines, and inflammatory markers and mammographic density among postmenopausal women. Breast Cancer Res Treat (2013) 0.85
Implementing world class commissioning competencies. J Health Serv Res Policy (2012) 0.85
Risk of endometrial cancer in relation to individual nutrients from diet and supplements. Public Health Nutr (2011) 0.85
Associations of overall and abdominal adiposity with area and volumetric mammographic measures among postmenopausal women. Int J Cancer (2010) 0.84
Risk assessment for inherited susceptibility to cancer: a review of the psychosocial and ethical dimensions. Genet Test (2005) 0.83
Anthropometric measures and the risk of endometrial cancer, overall and by tumor microsatellite status and histological subtype. Am J Epidemiol (2013) 0.83
Case-control study of dietary patterns and endometrial cancer risk. Nutr Cancer (2011) 0.83
Breaking the addiction to technology adoption. Health Econ (2014) 0.82
The evolution of PBMA: towards a macro-level priority setting framework for health regions. Health Care Manag Sci (2003) 0.82
Listening to the decision makers: sustainability of PBMA in Alberta. Appl Health Econ Health Policy (2004) 0.82
Do ordering effects matter in willingness-to-pay studies of health care? J Health Econ (2002) 0.82
To reuse or not to reuse? An economic evaluation of hemodialyzer reuse versus conventional single-use hemodialysis for chronic hemodialysis patients. Int J Technol Assess Health Care (2002) 0.82
Implicit versus explicit ranking: on inferring ordinal preferences for health care programmes based on differences in willingness-to-pay. J Health Econ (2005) 0.82
A stated preference approach to assessing health care-quality improvements in Palestine: from theoretical validity to policy implications. J Health Econ (2004) 0.82
Priority setting in healthcare: towards guidelines for the program budgeting and marginal analysis framework. Expert Rev Pharmacoecon Outcomes Res (2010) 0.82
Interaction of CDKN2A and sun exposure in the etiology of melanoma in the general population. J Invest Dermatol (2011) 0.82
Intrauterine devices and endometrial cancer risk: a pooled analysis of the Epidemiology of Endometrial Cancer Consortium. Int J Cancer (2014) 0.82
Cost-effectiveness of health-related lifestyle advice delivered by peer or lay advisors: synthesis of evidence from a systematic review. Cost Eff Resour Alloc (2013) 0.81
Valuing food safety improvements using willingness to pay. Appl Health Econ Health Policy (2003) 0.81
Resource allocation in health care: health economics and beyond. Health Care Anal (2003) 0.81
Comparing WTP values of different types of QALY gain elicited from the general public. Health Econ (2013) 0.81
Q-ing for health--a new approach to eliciting the public's views on health care resource allocation. Health Econ (2013) 0.80
Decision maker perceptions of resource allocation processes in Canadian health care organizations: a national survey. BMC Health Serv Res (2013) 0.80